Neuroinflammation in healthy aging: A PET study using a novel Translocator Protein 18kDa (TSPO) radioligand, [18F]-FEPPA
Ivonne Suridjan(AbbVie (United States)), Romina Mizrahi, Jeff Meyer(Centre for Addiction and Mental Health), Sylvain Houle, Elaine Setiawan(Centre for Addiction and Mental Health), Thiviya Selvanathan(University of Toronto), Antonio P. Strafella(Centre for Addiction and Mental Health), Aristotle N. Voineskos(Centre for Addiction and Mental Health), Alan A. Wilson(Centre for Addiction and Mental Health), Pablo Rusjan(Centre for Addiction and Mental Health)
Cited by 69
Related Papers
Changes in Regional Brain Glucose Metabolism Measured With Positron Emission Tomography After Paroxetine Treatment of Major Depression
|American Journal of Psychiatry|2001|700
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
|JAMA Neurology|2021|627
The Construct of Minor and Major Depression in Alzheimer’s Disease
|American Journal of Psychiatry|2005|271
Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging
|Annals of Neurology|2020|186
Neuroimaging Evidence for the Deficit Subtype of Schizophrenia
|JAMA Psychiatry|2013|175